1. In vitro activity of lomefloxacin (SC471 11; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones. Antimicrob Agents;Chin, N.-X.; Novelli, A.; Neu, N.C.;Chemother,1988
2. The comparative in-vitro activity of ofloxacin;Gruneberg, R.N.; Felmingham, D.; O'Hare, M.D.; Robbins, M.J.; Perry, K.; Wall, R.A.;J7Antimicrob Chemother,1988
3. In-vitro and in-vivo activities of T-3262, a new pyridone carboxylic acid;Takahata, M.; Otsuki, M.; Nishino, T.;J Antimicrob Chemother,1988
4. Safety and efficacy of topical norfloxacin versus tobramycin in the treatment of external ocular infections;Jacobson, J.A.; Call, N.B.; Kasworrn, E.M.; Dirks, M.S.; Turner, R.B.;Antimicrob Agents Chemother,1988
5. Ofloxacin compared with chloramphenicol in the management of external ocular infection;Bron, A.J.; Leber, G.; Rizk, S.N.M.; Elkington, Baig H.; AR, Kirkby;BrJ Ophthalmol,1991